Retention of adoptively transferred interleukin-2-activated natural killer cells in tumor tissue

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1115-1123

  Ribeiro Jr , Ulysses ^a   Basse, Per H ^b   Rosenstein, Maury ^a   Safatle Ribeiro, Adriana V ^a   Alhallak, Souheil ^b   Goldfarb, Ronald H ^b   Posner, Mitchell C ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

A NK cells; Interleukin 2; Perfusion; Tissue isolated tumors

Indexed keywords

FLUORESCENT DYE; INTERLEUKIN 2;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; TUMOR;

ADOPTIVE TRANSFER; ANIMALS; FEMALE; INTERLEUKIN-2; KILLER CELLS, NATURAL; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344;

EID: 1842289750     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mule JJ, Shu S, Schwarz SL, Rosenberg SA: Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225: 1487-1489, 1984.
2. Lafreniere R, Rosenberg SA: Adoptive immunotherapy of marine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin-2 (RIL-2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. J Immunol 135: 4273-4280, 1985.
3. Lafreniere R, Rosenberg SA: Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin-2. Cancer Res 45: 3735-3741, 1985.
4. Rosenberg SA, Yang JC, Topalian SL et al: Treatment of 238 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin-2. JAMA 271: 907-913, 1994.
5. Fleishmann JD, Kim B: lnterleukin-2 immunotherapy followed by resection of residual renal cell carcinoma. J Urol 145: 938-941, 1991.
6. Gunji Y, Vujanovic NL, Hiserodt JC, Herberman RB, Gorelik E: Generation and characterization of purified adherent lymphokine activated killer cells in mice. J Immunol 142: 1748-1754, 1989.
7. Vujanovic NL, Herberman RB, Maghazachi AA, Hiserodt JC: Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med 167: 15-29, 1988.
8. Schwarz RE, Vujanovic NL, Hiserodt JC: Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res 49: 1441-1446, 1989.
9. Henkart PA: Mechanism of lymphocyte-mediated cytotoxicity. Ann Rev Immunol 3: 31-58, 1985.
10. Basse PH, Nannmark U, Johansson BR, Herberman RB, Goldfarb RH: Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J Natl Cancer Inst 83: 944-950, 1991.
11. Sasaki A, Melder RJ, Whiteside TL, Herberman RB, Jain RK: Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculution. J Natl Cancer Inst 83: 433-437, 1991.
12. Chong AS, Scuderi P, Grimes WJ, Hersh EM: Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. J Immunol 142: 2133-2139, 1989.
13. Basse PH, Herberman RB, Nannmark U et al: Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J Exp Med 174: 479-488, 1991.
14. Basse PH, Herberman RB, Hokland ME, Goldfarb RH: Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration. Natural Immunity 11: 193-201, 1992.
15. Maghazaki AA, Herberman RB, Vujanovic NL, Hiserodt JC: in vivo distribution and tissue localization of highly purified rat lymphokineactivated killer (LAK) cells. Cell Immunol 115: 179-194, 1988.
16. Ames IH, Gagne GM, Garcia AM et al: Preferential homing of tumor-infiltrating lymphocytes in tumor-hearing mice. Cancer Immunol Immunother 29: 93-100, 1989.
17. Gullino PM and Grantham FH: Studies on the exchange of fluids between host and tumor. A method for growing "tissue-isolated" tumors in laboratory animals. J Natl Cancer Inst 27: 679-693, 1961.
18. Sevick EM, Jain RK: Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. Cancer Res 49: 3506-3512, 1988.
19. Griffith KD, Read EJ, Carrasquillo JA et al: in vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst 81: 1709-1717, 1989.
20. Sasaki A, Jain RK, Maghazachi AA, Goldfarb RH, Herberman RB: Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. Cancer Res 49: 3742-3746, 1989.
21. Kuppen PJK, Basse PH, Goldfarb RH, Van De Velde CJH, Fleuren GJ, Eggermont AMM: The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats. Int J Cancer 56: 574-579, 1994.
22. Jain RK: Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658, 1988.
23. Jain RK: Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 81: 570-576, 1989.
24. Melder RJ, Walke ER, Herberman RB, Whiteside TL: Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells. J Leukoc Biol 48: 163-173, 1990.
25. Less JR, Skalak TC, Sevick EM, Jain RK: Microvascular architeture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 51: 265-273, 1991.
26. Maenpaa A, Jaaskelainen J, Patarroyo M, Timonen T: Expression of adhesion molecules on NK and T cells: impact of IL-2. Nat Immun Cell Growth Regul 10: 135-136, 1991.
27. Picker LJ: Mechanisms of lymphocytes homing. Curr Opin Immunol 4: 277-286, 1992.
28. Lipowski HH, House SD, Firrell JC: Leukocyte endothelium adhesion and microvascular hemodynamics. Adv Exp Med Biol 242: 85-93, 1988.
29. Wu NZ, Klitzman B, Dodge R, Dewhirst MW: Diminished leukocyte endothelium interaction in tumor microvessels. Cancer Res 52: 4265-4268, 1992.